학술논문
Profound MRD negativity rates after frontline tandem autologous-allogeneic stem cell transplantation followed by bortezomib maintenance in high-risk or young myeloma patients
Document Type
Abstract
Author
Source
In Clinical Lymphoma, Myeloma and Leukemia October 2019 19(10) Supplement:e41-e42
Subject
Language
ISSN
2152-2650